DRUG DISCOVERY ONLINE EDITORIAL ADVISORY BOARD
Drug discovery is entering a new era, one defined by AI, advanced biology, new approach methodologies, novel therapeutic modalities, and an unprecedented pace of innovation.
The Drug Discovery Online Editorial Advisory Board brings together a global community of experts spanning target discovery, computational biology, screening, lead optimization, translational medicine, biologics, cell and gene therapies, investing, and drug development leadership.
Their collective expertise helps guide our editorial direction, spotlight emerging breakthroughs, and foster meaningful conversations across the worldwide drug discovery ecosystem.
If you’re serious about where drug discovery is going and you'd like to be considered for membership? Reach out to Ray Dogum.
Zaher Nahle, Senior Scientific Advisor (CHE)/Founder & CEO (Ivyctory Group)Center for a Humane Economy (CHE) & The Ivyctory Group









